53 stories tagged with #obesity, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Obesity"
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.…
Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know
Roche vs Pfizer in the booming GLP-1 obesity/T2D market: Phase 2 enicepatide vs berobenatide claims, pipeline strength, and why Roche leads—read now.…
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology…
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide…
Drinking alcohol may influence cravings for certain foods in a surprising way, study suggests
People who reported drinking alcohol also reported eating a lot more savory foods and fewer sweet foods than the non-drinkers.…
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Rhythm Pharmaceuticals: The Rare Obesity Platform Is Becoming A Commercial Engine
Rhythm Pharma (RYTM) growth outlook: IMCIVREE approvals for hypothalamic obesity, rapid uptake, catalysts, and pipeline. See more details here.…
There’s a reason you crave salty foods when you drink. And it’s driving weight gain
Ever wondered why cheese and chardonnay pair so perfectly, or why you crave pizza with a beer? It’s called the aperitif effect.…
Surgery or Meds for Weight Regain After Sleeve Gastrectomy?
A retrospective study finds that conversion surgery after sleeve gastrectomy produces greater long-term weight loss than obesity medications for recurrent weight gain.…
Weight-loss drugs may prevent thousands of knee replacements, study suggests
Patients with knee arthritis who took medications for at least three years at reduced risk of needing surgery Taking weight-loss drugs for at least three years could prevent thousa…
Prevalence of diabetes continues to climb in southern States: NFHS
NFHS-6 reveals rising diabetes and obesity rates in southern India, highlighting Andhra Pradesh, Kerala, and Tamil Nadu as key hotspots.…
National Family Health Survey-6: Kerala leads in women’s obesity and NCD prevalence
NFHS-6 reveals Kerala's obesity crisis and rising NCDs, despite improvements in child health and immunization coverage.…
NFHS-6: Hospital births rise in India, but lifestyle disease crisis looms
Along with the rise in hospital births, the NFHS-6 report cited an increase in percentage of deliveries attended by skilled health personnel from 89.4% to 91.3% | India News…
Higher Abdominal Fat Linked to Faster Biological Aging
Higher abdominal fat is associated with accelerated biological aging across multiple measures, and metabolic aging explains much of the increased risks for heart disease and death.…
Does Obesity Drive Related Conditions in Older Adults?
Many health conditions related to obesity are common in older adults, but some are more attributable to obesity than others.…
CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters
CVS brings back coverage for Lilly's obesity drug Zepbound Reuters…
Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.…
EMA Backs Options for Broadening Obesity Care in Europe
EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment options for diabetes and weight management across Europe…
Drinking tomato-soy juice loaded with lycopene and soy isoflavones lowered pro-inflammatory proteins in healthy adults with obesity after 4 weeks, a study found. With NIH funding, the researchers are now testing whether the juice reduces inflammation in people with pancreatitis.
Weight-Loss Pill Approval Highlights Important Role of PCPs
FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity medications.…
Cooling Vest May Reduce Body Fat in Obesity
Wearing a cooling vest for a few hours each morning may aid weight loss and reduce fat mass in adults with overweight or obesity.…
Is the End of the Obesity Epidemic Near?
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.…
Eli Lilly (LLY) Announces Positive Phase 3 Results for Obesity Treatment Retatrutide
Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.…
Obesity-Related Asthma: Is Inflammation Driving Severity?
Emerging evidence suggests that leptin, dysbiosis, and altered innate immunity may contribute to poor asthma control in patients with obesity.…
Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Ze…
Retatrutide Delivers Unprecedented Weight Loss in Phase 3
Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.…
New obesity drug from Lilly delivers major weight loss
New weight-loss shot appears to outperform other obesity drugs on market
Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs A new weight-loss drug has helped participants in a sizable …
New Eli Lilly weight loss drug has dramatic effects in clinical trial
An experimental anti-obesity injection helped patients reach new levels of weight loss previously only achievable through bariatric surgery, according to new data from the pharmace…
Eli Lilly says next-generation weight loss drug clears crucial obesity trial
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.…
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the effectiveness seen with bariatric surgery…
Eli Lilly's next-generation weight loss injection posted record results in obesity trial
New obesity treatment may help preserve muscle during weight loss
Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.…
AI atlas reveals hidden whole-body-damage caused by obesity
Could Digital Obesity Care Help Improve the Economy?
A UK digital obesity programme was associated with > 40% fewer GP visits and markedly lower long-term sick leave within 9 months in a real-world analysis.…
Experts Debate Weight-Loss Controversies
Microdosing, drugs vs surgery, hormone replacement therapy to induce weight loss, and confusing nomenclature for loss of muscle function were among the hot topics at Obesity Medici…
EASO Update Gives Clearer Roles for Tirzepatide, Semaglutide
EASO’s ‘living’ algorithm has been updated with the latest evidence, strengthening tirzepatide’s position for weight loss and semaglutide’s role in liver fibrosis improvement.…
Obesity rates plateaued or slightly declined in several high-income countries, while obesity continued rising across most low-income and middle-income countries despite already surpassing prevalence levels seen in wealthier nations, according to data from 232 million people between 1980 and 2024
Low Natriuretic Peptide Levels in Obesity? HF Risk Persists
Adults with obesity may have natriuretic peptide levels below the usual rule-out threshold and still have increased odds of signs and symptoms of heart failure and other risks.…
Maternal Overnutrition Linked to Obesity in Adult Offspring
Maternal overnutrition is associated with a higher likelihood of obesity in adult offspring, with effects persisting into adulthood and being more pronounced in women.…
Human Coaching Boosts Adherence in AI Wearable Obesity Study
The results suggest that hybrid models may outperform fully automated approaches.…
A Practical Guide to Make Digital Tools Work With GLP-1s
The learning curve can be steep for patients trying apps, wearables, and telehealth platforms. Your expertise is needed.…
Caliway presents preclinical data on CBL-514 at obesity congress
'Two years to live': Why we used our super for weight loss surgery
Weight loss surgery has become an increasingly common option for people grappling with obesity — and many are funding it using retirement savings.…
Is Persistent Hunger After Weight Loss Behind Weight Regain?
People who regain lost weight may be biologically driven to do so via hyperphagia, an insatiable hunger and an intense preoccupation with food.…
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.…
Novo Nordisk’s next obesity battlefront: Winning beyond America
The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world.…
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
New study debunks the biggest fear about yo-yo dieting
For years, “yo-yo dieting” has been blamed for wrecking metabolism and causing lasting damage, but a major new review says the fear may be wildly overblown. After analyzing decades…
Experimental weight-loss drug outperforms original GLP-1s
An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.…
Prediabetes Tied to Weight Regain After Bariatric Surgery
Prediabetes may leave an enduring molecular ‘footprint’ on fat tissue that makes maintaining weight loss after bariatric surgery more difficult.…